Studies have shown baloxavir to be a standout among antivirals commonly used for influenza
— Studies have shown baloxavir to be a standout among antivirals commonly used for influenza
by Ian Ingram, Managing Editor, MedPage Today
June 19, 2026
• 2 min read
The FDA this week approved the first generic version of baloxavir marboxil (Xofluza) as a single-dose option to treat or prevent influenza in adults and children 5 years and up.
New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel
Key FDA committee unanimously recommends its first vaccine since 2023
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
FDA advisors back approval of mRNA flu shot
New mRNA flu vaccine faces scrutiny ahead of key FDA decision
FDA approves Priftin generic for two types of tuberculosis
FDA approves Moderna's new mRNA-based flu vaccine | The Jerusalem Post
Moderna flu vaccine wins unanimous support from FDA panel
FDA panel recommends Moderna’s mRNA flu shot for older adults
Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Moderna (NASDAQ:MR
Roche has signed a voluntary license agreement providing its popular influenza antiviral drug Xofluza (baloxavir marboxil) for…
Alembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for…
Shionogi won FDA approval for Xocova, an oral antiviral to prevent Covid-19 after exposure in people 12 and older who've been in…
WASHINGTON (AP) – A new kind of flu vaccine moved a step closer to the U.S.
Ensitrelvir cut household contacts' risk of developing COVID by more than half
Moderna's novel vaccine was at the center of dustup with agency earlier this year
